Manmeet Singh Soni - Net Worth and Insider Trading

Manmeet Singh Soni Net Worth

The estimated net worth of Manmeet Singh Soni is at least $25 Million dollars as of 2024-03-01. Manmeet Singh Soni is the COO of Summit Therapeutics Inc and owns about 2,976,190 shares of Summit Therapeutics Inc (SMMT) stock worth over $14 Million. Manmeet Singh Soni is the COO, CFO and President of Reata Pharmaceuticals Inc and owns about 62,621 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $11 Million. Manmeet Singh Soni is also the Director of Arena Pharmaceuticals Inc and owns about 5,902 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $590,141. Details can be seen in Manmeet Singh Soni's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Manmeet Singh Soni has not made any transactions after 2023-10-13 and currently still holds the listed stock(s).

Transaction Summary of Manmeet Singh Soni

To

Manmeet Singh Soni Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Manmeet Singh Soni owns 6 companies in total, including Summit Therapeutics Inc () , Reata Pharmaceuticals Inc () , and Arena Pharmaceuticals Inc () among others .

Click here to see the complete history of Manmeet Singh Soni’s form 4 insider trades.

Insider Ownership Summary of Manmeet Singh Soni

Ticker Comapny Transaction Date Type of Owner
Summit Therapeutics Inc 2023-10-13 director
Reata Pharmaceuticals Inc 2023-09-26 COO & CFO and President
Arena Pharmaceuticals Inc 2020-06-17 director
Pulse Biosciences Inc 2022-05-19 director
Alnylam Pharmaceuticals Inc 2017-05-09 Chief Financial Officer
ARIAD Pharmaceuticals Inc 2017-02-16 EVP & CFO & Treasurer

Manmeet Singh Soni Latest Holdings Summary

Manmeet Singh Soni currently owns a total of 3 stocks. Among these stocks, Manmeet Singh Soni owns 2,976,190 shares of Summit Therapeutics Inc (SMMT) as of October 13, 2023, with a value of $14 Million and a weighting of 54.84%. Manmeet Singh Soni owns 62,621 shares of Reata Pharmaceuticals Inc (RETA) as of August 16, 2023, with a value of $11 Million and a weighting of 42.82%. Manmeet Singh Soni also owns 5,902 shares of Arena Pharmaceuticals Inc (ARNA) as of June 17, 2020, with a value of $590,141 and a weighting of 2.34%.

Latest Holdings of Manmeet Singh Soni

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SMMT Summit Therapeutics Inc 2023-10-13 2,976,190 4.65 13,824,403
RETA Reata Pharmaceuticals Inc 2023-08-16 62,621 172.36 10,793,356
ARNA Arena Pharmaceuticals Inc 2020-06-17 5,902 99.99 590,141

Holding Weightings of Manmeet Singh Soni


Manmeet Singh Soni Form 4 Trading Tracker

According to the SEC Form 4 filings, Manmeet Singh Soni has made a total of 1 transactions in Summit Therapeutics Inc (SMMT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Summit Therapeutics Inc is the acquisition of 2,976,190 shares on October 13, 2023, which cost Manmeet Singh Soni around $5 Million.

According to the SEC Form 4 filings, Manmeet Singh Soni has made a total of 8 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 2 buys and 6 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 1,755 shares on August 16, 2023, which brought Manmeet Singh Soni around $295,560.

According to the SEC Form 4 filings, Manmeet Singh Soni has made a total of 3 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 304 shares on June 17, 2020, which brought Manmeet Singh Soni around $19,073.

Insider Trading History of Manmeet Singh Soni

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Manmeet Singh Soni Trading Performance

GuruFocus tracks the stock performance after each of Manmeet Singh Soni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Manmeet Singh Soni is 60.18%. GuruFocus also compares Manmeet Singh Soni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Manmeet Singh Soni within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Manmeet Singh Soni's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Manmeet Singh Soni

Average Relative Return

24.03%

Average relative return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 5.15 60.18 18.25 24.03 -54.75 18.31
Relative Return to S&P 500(%) 6.15 56.22 19.79 17.51 -67.44 8.31

Manmeet Singh Soni Ownership Network

Ownership Network List of Manmeet Singh Soni

No Data

Ownership Network Relation of Manmeet Singh Soni


Manmeet Singh Soni Owned Company Details

What does Summit Therapeutics Inc do?

Who are the key executives at Summit Therapeutics Inc?

Manmeet Singh Soni is the director of Summit Therapeutics Inc. Other key executives at Summit Therapeutics Inc include Chief Financial Officer Ankur Dhingra , director & 10 percent owner & See Remarks Robert W Duggan , and VP & Corporate Controller Jeffrey R Maranian .

Summit Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Manmeet Singh Soni made 1 insider transaction in Summit Therapeutics Inc () with a net purchase of 2,976,190. Other recent insider transactions involving Summit Therapeutics Inc () include a net purchase of 47,059,088 shares made by Maky Zanganeh , a net purchase of 216,762 shares made by Ankur Dhingra , and a net purchase of 376,489,880 shares made by Robert W Duggan .

In summary, during the past 3 months, insiders sold 0 shares of Summit Therapeutics Inc () in total and bought 25,400 shares, with a net purchase of 25,400 shares. During the past 18 months, 0 shares of Summit Therapeutics Inc () were sold and 426,741,920 shares were bought by its insiders, resulting in a net purchase of 426,741,920 shares.

Summit Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Summit Therapeutics Inc Insider Transactions

No Available Data

Manmeet Singh Soni Mailing Address

Above is the net worth, insider trading, and ownership report for Manmeet Singh Soni. You might contact Manmeet Singh Soni via mailing address: C/o Pharmacyclics, Inc., 995 East Arques Ave, Sunnyvale Ca 94085.

Discussions on Manmeet Singh Soni

No discussions yet.